[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341126-105":59,"doc-detail-341126-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-infiltrating-lymphocytes-and-breast-cancer-mortality-in-racially-and-ethnically-diverse-participants-of-the-northern-california-breast-cancer-family-registry-brief-communications","Tumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California Breast Cancer Family Registry - Brief Communications","","Stromal tumor-infiltrating lymphocyte (sTIL) enrichment in pretreatment breast tumors is linked to improved neoadjuvant response and survival. In a population-based cohort, sTIL-survival associations were evaluated by race and ethnicity, using continuous sTIL scores and sTIL-enriched classifications at 30%, 50%, and 70% infiltration cutoffs. No race/ethnicity differences emerged for sTIL score overall, but higher continuous sTIL correlated with lower breast cancer–specific mortality only among non-Hispanic White and Asian American women, not among African American or Hispanic women. The findings indicate complex determinants of treatment response and survival and support further study of patient selection for sTIL-guided strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-infiltrating-lymphocytes-and-breast-cancer-mortality-in-racially-and-ethnically-diverse-participants-of-the-northern-california-breast-cancer-family-registry-brief-communications/341126/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-infiltrating-lymphocytes-and-breast-cancer-mortality-in-racially-and-ethnically-diverse-participants-of-the-northern-california-breast-cancer-family-registry-brief-communications/341126.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does stromal tumor-infiltrating lymphocyte (sTIL) enrichment represent in pretreatment breast tumors?","Question",{"text":112,"@type":113},"sTIL enrichment reflects the level of lymphocytic infiltration in the tumor stroma, quantified as continuous sTIL scores or as enriched categories using predefined cutoffs (30%, 50%, 70%).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did sTIL score differ across racial and ethnic groups?",{"text":117,"@type":113},"No difference in sTIL score was identified by race and ethnicity in the studied population-based cohort.",{"name":119,"@type":110,"acceptedAnswer":120},"Which groups showed an association between higher continuous sTIL score and lower breast cancer–specific mortality?",{"text":121,"@type":113},"Higher continuous sTIL score was associated with lower breast cancer–specific mortality among non-Hispanic White and Asian American women, but not among African American and Hispanic women.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341126,1790438058,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","JNCI Cancer Spectrum, 2024, 8(2), pkae023  \n[https://doi.org/10.1093/jncics/pkae023](https://doi.org/10.1093/jncics/pkae023)  \nAdvance Access Publication Date: March 28, 2024  \nBrief Communications  \nTumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California Breast Cancer Family Registry  \nJulia D. Ransohoff , MD,1,2 Iain Miller, MD,3 Jocelyn Koo, BA,2 Vishal Joshi, BA,1 Allison W. Kurian, MD, MSc,1,2,4 Kimberly H. Allison, MD,2,3 Esther M. John , PhD, MSPH,1,2,4,‡ Melinda L. Telli , MD1,2,4,‡,􀀃  \n1Department of Medicine (Oncology), Stanford University School of Medicine, Palo Alto, CA, USA 2Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA 3Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA  \n4Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, CA, USA  \n􀀃 Correspondence to: Melinda L. Telli, MD, Department of Medicine (Oncology), Stanford University School of Medicine, 900 Welch Rd, Ste 100, Rm 104, Palo Alto, CA 94305, USA ([e-mail: mtelli@stanford.edu](e-mail: mtelli@stanford.edu)) .  \n‡These authors contributed equally to this work.  \nAbstract  \nStromal tumor-infiltrating lymphocyte (sTIL) enrichment in pretreatment breast tumors has been associated with superior response to neoadjuvant treatment and survival. In a population-based cohort, we studied sTIL-survival associations by race and ethnicity. We assessed associations of continuous sTIL scores and sTIL-enriched breast cancers (defined as percent lymphocytic infiltration of tumor stroma or cell nests at cutoffs of 30%, 50%, and 70%) with clinical and epidemiologic characteristics and conducted multivariable survival analyses. Although we identified no difference in sTIL score by race and ethnicity, higher continuous sTIL score was associated with lower breast cancer–specific mortality only among non-Hispanic White and Asian American but not African American and Hispanic women. This finding suggests that complex factors influence treatment response and survival, given thatsTIL enrichment was not associated with a survival advantage among women from minoritized groups, who more often experience health disparities. Further study of patient selection for sTIL-guided treatment strategies is warranted.  \nStromal tumor-infiltrating lymphocyte (sTIL) enrichment in pretreatment breast cancer specimens predicts better response toneoadjuvant chemotherapy (1), improved disease-free and overall survival in early-stage triple-negative breast cancer (TNBC) treated with chemotherapy (2 ,3), and higher pathologic complete response rate and disease-free survival in HER2-positive disease (4) . More recent data suggest an association between sTILs and response to checkpoint inhibitor monotherapy in metastatic TNBC (5) and to combination neoadjuvant chemoimmunotherapy (6) . Identifying characteristics associated with sTILs and survival may inform therapeutic escalation or de-escalation strategies. Prior sTIL studies focused primarily on non-Hispanic White (NHW) patients and demonstrated geographic variation insTIL scores (4 ,7), suggesting that differences in race and ethnicity, genetics, or exposures may drive antitumor immunity.  \nWe assessed sTIL associations with clinical, epidemiologic, and genetic characteristics and survival outcomes in the Northern California Breast Cancer Family Registry (NC-BCFR)(8 ,9) . We hypothesized that sTIL-survival associations vary by race and ethnicity.  \nMethods  \nThe study was based on women diagnosed at younger than age 65 years with a first primary invasive breast cancer ascertained  \nthrough the population-based Greater Bay Area Cancer Registry. Cases diagnosed younger than age 35 years, with a family history of breast cancer, and from minoritized populations were oversampled per the NC-BCFR sampling scheme, as previously described (9) . All research was app","cbCaimOG12ngrkxD","https://ap.wps.com/l/cbCaimOG12ngrkxD","pdf",790842,"English","# Abstract\n# Methods","[{\"question\":\"What does stromal tumor-infiltrating lymphocyte (sTIL) enrichment represent in pretreatment breast tumors?\",\"answer\":\"sTIL enrichment reflects the level of lymphocytic infiltration in the tumor stroma, quantified as continuous sTIL scores or as enriched categories using predefined cutoffs (30%, 50%, 70%).\"},{\"question\":\"How did sTIL score differ across racial and ethnic groups?\",\"answer\":\"No difference in sTIL score was identified by race and ethnicity in the studied population-based cohort.\"},{\"question\":\"Which groups showed an association between higher continuous sTIL score and lower breast cancer–specific mortality?\",\"answer\":\"Higher continuous sTIL score was associated with lower breast cancer–specific mortality among non-Hispanic White and Asian American women, but not among African American and Hispanic women.\"}]","Tumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California Breast Cancer Family Registry - Brief Communications | PDF",1790040434,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81f0c320994a20fe7f9f2a4bcb056b07.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bf98c603fa0ae96bda27151b15154b4.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/776d8bcdcba444530f2218b3589d0355.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59769fcb12a048e4f7694c0faf54bdcd.webp",980,1287]